The effects of B cell stimulatory factor 1 (BSF-1) on the generation of human CTL and lymphokine-activated killer (LAK) cells in vitro were investigated. Both L-2 and BSF-1 were potent helper factors for the generation of antigen-specific CTL in MLC; detection of optimal BSF-1-induced CTL activity in this system occurred when BSF-1 was added to cultures after an initial period of activation during which exogenous BSF-1 was not present. In contrast to IL-2, BSF-1 failed to induce an LAK cell population, as detected with Daudi tumor targets, in cultures that had not been allosensitized. Furthermore, when both lymphokines were added together at culture initiation, BSF-1 inhibited the IL-2-driven generation of cytolytic cells. The differential ability of BSF-1 to promote the generation of CTL but not LAK could have important implications for lymphokine-mediated immunotherapy.
Skip Nav Destination
Article navigation
1 November 1987
Article|
November 01 1987
Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).
M B Widmer,
M B Widmer
Immunex Corporation, Seattle, Washington 98101.
Search for other works by this author on:
R B Acres,
R B Acres
Immunex Corporation, Seattle, Washington 98101.
Search for other works by this author on:
H M Sassenfeld,
H M Sassenfeld
Immunex Corporation, Seattle, Washington 98101.
Search for other works by this author on:
K H Grabstein
K H Grabstein
Immunex Corporation, Seattle, Washington 98101.
Search for other works by this author on:
M B Widmer
Immunex Corporation, Seattle, Washington 98101.
R B Acres
Immunex Corporation, Seattle, Washington 98101.
H M Sassenfeld
Immunex Corporation, Seattle, Washington 98101.
K H Grabstein
Immunex Corporation, Seattle, Washington 98101.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1987) 166 (5): 1447–1455.
Citation
M B Widmer, R B Acres, H M Sassenfeld, K H Grabstein; Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).. J Exp Med 1 November 1987; 166 (5): 1447–1455. doi: https://doi.org/10.1084/jem.166.5.1447
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement